Correlation Between MaxCyte and Hyperfine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Hyperfine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Hyperfine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Hyperfine, you can compare the effects of market volatilities on MaxCyte and Hyperfine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Hyperfine. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Hyperfine.

Diversification Opportunities for MaxCyte and Hyperfine

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between MaxCyte and Hyperfine is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Hyperfine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyperfine and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Hyperfine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyperfine has no effect on the direction of MaxCyte i.e., MaxCyte and Hyperfine go up and down completely randomly.

Pair Corralation between MaxCyte and Hyperfine

Given the investment horizon of 90 days MaxCyte is expected to under-perform the Hyperfine. But the stock apears to be less risky and, when comparing its historical volatility, MaxCyte is 4.06 times less risky than Hyperfine. The stock trades about -0.41 of its potential returns per unit of risk. The Hyperfine is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  99.00  in Hyperfine on November 28, 2024 and sell it today you would lose (2.00) from holding Hyperfine or give up 2.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MaxCyte  vs.  Hyperfine

 Performance 
       Timeline  
MaxCyte 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MaxCyte are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, MaxCyte may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Hyperfine 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Hyperfine are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Hyperfine may actually be approaching a critical reversion point that can send shares even higher in March 2025.

MaxCyte and Hyperfine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MaxCyte and Hyperfine

The main advantage of trading using opposite MaxCyte and Hyperfine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Hyperfine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyperfine will offset losses from the drop in Hyperfine's long position.
The idea behind MaxCyte and Hyperfine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device